• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

潜在托烷5-羟色胺、5-羟色胺和多巴胺受体配体的构效关系研究。

Model structure-activity relationship studies of potential tropane 5HT, 5HT, and D receptor ligands.

作者信息

Słowiński Tomasz, Stefanowicz Jacek, Wróbel Martyna Z, Herold Franciszek, Mazurek Andrzej, Pluciński Franciszek, Mazurek Aleksander P, Wolska Irena

机构信息

Department of Drug Technology and Pharmaceutical Biotechnology, Medical University of Warsaw, 1 Banacha Str., 02-097 Warsaw, Poland.

出版信息

Med Chem Res. 2013 Jul;22(7):3148-3153. doi: 10.1007/s00044-012-0305-6. Epub 2012 Nov 11.

DOI:10.1007/s00044-012-0305-6
PMID:23710122
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3661918/
Abstract

The two-stages studies of structure-activity relationship for model ligands of 5HT, 5HT, and D receptors were performed. On the first stage, the pharmacophores of two potential ligands of known in vitro binding to 5HT, 5HT, D receptors and model pharmacophore of strongly interacting D receptor ligands were found and their parameters were related to affinity data. The analyzed parameters were hydrophobic, hydrophilic, aromatic, donor and acceptor of proton centers. The geometry of spatial distribution of these properties was also investigated in comparative analysis. The studied, model compounds were two 3β-acylamine derivatives of tropane. The second stage includes docking of studied compounds to D receptor model and the comparison of its quality with in vivo binding data. The obtained results are consistent with in vitro binding data and applied procedure accurate estimates the affinity of potential ligands to D receptors.

摘要

对5-羟色胺(5HT)、5HT和多巴胺(D)受体的模型配体进行了两阶段的构效关系研究。在第一阶段,发现了两种已知体外与5HT、5HT、D受体结合的潜在配体的药效基团以及与D受体配体强相互作用的模型药效基团,并将它们的参数与亲和力数据相关联。分析的参数有疏水、亲水、芳香、质子中心的供体和受体。在比较分析中还研究了这些性质的空间分布几何结构。所研究的模型化合物是两种托烷的3β-酰胺衍生物。第二阶段包括将所研究的化合物与D受体模型对接,并将其质量与体内结合数据进行比较。所得结果与体外结合数据一致,所应用的程序准确地估计了潜在配体对D受体的亲和力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/3661918/eb34f8e710a8/44_2012_305_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/3661918/855b9dfeae43/44_2012_305_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/3661918/0625aee50b6d/44_2012_305_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/3661918/7dd569990b91/44_2012_305_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/3661918/9d3b39407763/44_2012_305_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/3661918/169795a04336/44_2012_305_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/3661918/4b2cea0469ab/44_2012_305_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/3661918/0c2c4a09db18/44_2012_305_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/3661918/eb34f8e710a8/44_2012_305_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/3661918/855b9dfeae43/44_2012_305_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/3661918/0625aee50b6d/44_2012_305_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/3661918/7dd569990b91/44_2012_305_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/3661918/9d3b39407763/44_2012_305_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/3661918/169795a04336/44_2012_305_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/3661918/4b2cea0469ab/44_2012_305_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/3661918/0c2c4a09db18/44_2012_305_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/3661918/eb34f8e710a8/44_2012_305_Fig8_HTML.jpg

相似文献

1
Model structure-activity relationship studies of potential tropane 5HT, 5HT, and D receptor ligands.潜在托烷5-羟色胺、5-羟色胺和多巴胺受体配体的构效关系研究。
Med Chem Res. 2013 Jul;22(7):3148-3153. doi: 10.1007/s00044-012-0305-6. Epub 2012 Nov 11.
2
Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.利培酮与新型及参比抗精神病药物的比较:体外和体内受体结合情况
Psychopharmacology (Berl). 1996 Mar;124(1-2):57-73. doi: 10.1007/BF02245606.
3
Synthesis and biological investigations of 3β-aminotropane arylamide derivatives with atypical antipsychotic profile.具有非典型抗精神病药特性的3β-氨基托烷芳基酰胺衍生物的合成及生物学研究
Med Chem Res. 2018;27(8):1906-1928. doi: 10.1007/s00044-018-2203-z. Epub 2018 Jun 22.
4
Dibenzazecine compounds with a novel dopamine/5HT2A receptor profile and 3D-QSAR analysis.具有新型多巴胺/5HT2A受体特征的二苯氮杂䓬化合物及三维定量构效关系分析
BMC Pharmacol. 2006 Sep 15;6:11. doi: 10.1186/1471-2210-6-11.
5
Synthesis of several substituted phenylpiperazines behaving as mixed D2/5HT1A ligands.几种作为D2/5HT1A混合配体的取代苯基哌嗪的合成。
J Pharm Pharmacol. 1997 Oct;49(10):1036-41. doi: 10.1111/j.2042-7158.1997.tb06037.x.
6
Structure-Based Virtual Screening for Dopamine D2 Receptor Ligands as Potential Antipsychotics.基于结构的多巴胺D2受体配体虚拟筛选作为潜在抗精神病药物
ChemMedChem. 2016 Apr 5;11(7):718-29. doi: 10.1002/cmdc.201500599. Epub 2016 Mar 18.
7
Novel benzothiazolin-2-one and benzoxazin-3-one arylpiperazine derivatives with mixed 5HT1A/D2 affinity as potential atypical antipsychotics.具有混合5HT1A/D2亲和力的新型苯并噻唑啉-2-酮和苯并恶嗪-3-酮芳基哌嗪衍生物作为潜在的非典型抗精神病药物。
J Med Chem. 1998 Jun 4;41(12):2010-8. doi: 10.1021/jm970298c.
8
Comparison of 5-HT1A and dopamine D2 pharmacophores. X-ray structures and affinities of conformationally constrained ligands.5-羟色胺1A与多巴胺D2药效基团的比较。构象受限配体的X射线结构与亲和力。
J Med Chem. 1993 May 14;36(10):1301-15. doi: 10.1021/jm00062a001.
9
CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.基于比较分子力场分析(CoMFA)对重组D1和D2多巴胺受体激动剂亲和力的预测
J Med Chem. 1998 Oct 22;41(22):4385-99. doi: 10.1021/jm9800292.
10
Synthesis and biological investigation of new equatorial (β) stereoisomers of 3-aminotropane arylamides with atypical antipsychotic profile.具有非典型抗精神病药特性的3-氨基托烷芳基酰胺新的赤道(β)立体异构体的合成与生物学研究
Bioorg Med Chem. 2016 Sep 15;24(18):3994-4007. doi: 10.1016/j.bmc.2016.06.038. Epub 2016 Jun 20.

引用本文的文献

1
Synthesis and biological investigations of 3β-aminotropane arylamide derivatives with atypical antipsychotic profile.具有非典型抗精神病药特性的3β-氨基托烷芳基酰胺衍生物的合成及生物学研究
Med Chem Res. 2018;27(8):1906-1928. doi: 10.1007/s00044-018-2203-z. Epub 2018 Jun 22.

本文引用的文献

1
Computational drug discovery.计算药物发现。
Acta Pharmacol Sin. 2012 Sep;33(9):1131-40. doi: 10.1038/aps.2012.109. Epub 2012 Aug 27.
2
Synthesis and biological investigation of potential atypical antipsychotics with a tropane core. Part 1.合成和具有托烷核心的潜在非典型抗精神病药物的生物学研究。第 1 部分。
Eur J Med Chem. 2011 Sep;46(9):4474-88. doi: 10.1016/j.ejmech.2011.07.022. Epub 2011 Jul 26.
3
Studying the catechol binding cavity in comparative models of human dopamine D2 receptor.研究人类多巴胺 D2 受体比较模型中的儿茶酚结合腔。
J Mol Graph Model. 2011 Feb;29(5):685-92. doi: 10.1016/j.jmgm.2010.11.012. Epub 2010 Dec 2.
4
Subtype selectivity of dopamine receptor ligands: insights from structure and ligand-based methods.多巴胺受体配体的亚型选择性:结构和基于配体方法的见解。
J Chem Inf Model. 2010 Nov 22;50(11):1970-85. doi: 10.1021/ci1002747. Epub 2010 Oct 11.
5
The influence of drug-like concepts on decision-making in medicinal chemistry.类药概念对药物化学决策的影响。
Nat Rev Drug Discov. 2007 Nov;6(11):881-90. doi: 10.1038/nrd2445.
6
High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.一种工程化人β2-肾上腺素能G蛋白偶联受体的高分辨率晶体结构
Science. 2007 Nov 23;318(5854):1258-65. doi: 10.1126/science.1150577. Epub 2007 Oct 25.
7
Development of quantitative structure-activity relationships and its application in rational drug design.定量构效关系的发展及其在合理药物设计中的应用。
Curr Pharm Des. 2006;12(35):4601-11. doi: 10.2174/138161206779010431.
8
Pharmacophore models for metabotropic 5-HT receptor ligands.代谢型5-羟色胺受体配体的药效团模型。
Curr Top Med Chem. 2006;6(18):2005-26. doi: 10.2174/156802606778522186.
9
Computational methods in developing quantitative structure-activity relationships (QSAR): a review.开发定量构效关系(QSAR)中的计算方法:综述
Comb Chem High Throughput Screen. 2006 Mar;9(3):213-28. doi: 10.2174/138620706776055539.
10
Intrinsic activity and comparative molecular dynamics of buspirone analogues at the 5-HT(1A) receptors.
Biochem Pharmacol. 2004 Jun 15;67(12):2219-30. doi: 10.1016/j.bcp.2004.02.026.